Selected HighlightsThird quarter Operating EBITDA* of negative $28.1 million (net loss of $80.8 million), including a non-cash inventory impairment of $20.4 million, compared to positive $50.5 million (net loss of $17.6 million) in the same quarter of 2024 Combined industry wide challenges stemming from the global economic and trade environment, higher fiber costs and pulp grade substitution intensified in the third quarter of 2025 Continued execution of our “One Goal One Hundred” program, targeting $100 million in cost savings and operational efficiency actions by the end of 2026 and taking additional steps aimed at improving liquidity through further cost reductions, lowering capital expenditures in 2026 and other working capital measuresNEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Mercer International Inc. (Nasdaq:...

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — Valhi, Inc. (NYSE: VHI) reported a net loss attributable to Valhi stockholders of $22.2 million, or $.78 per share, in the third quarter of 2025 compared to net income of $57.5 million, or $2.01 per share, in the third quarter of 2024. For the first nine months of 2025, Valhi reported a net loss attributable to Valhi stockholders of $4.4 million, or $.15 per share, compared to net income of $85.2 million, or $2.99 per share, in the first nine months of 2024. Net income attributable to Valhi stockholders decreased in the third quarter and first nine months of 2025 as compared to the same periods in 2024 primarily due to lower operating results from the Chemicals Segment, a third quarter non-cash gain in 2024 related to the Chemicals Segment acquisition of the 50% joint venture interest...

Announces signing of $37.8m Supply Assurance Agreement with Merck Organizational changes streamline company and reduce operational expenses Cash runway extended through 2027 REDWOOD CITY, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for the efficient and scalable manufacturing of complex therapeutics, today announced financial results for the third quarter ended September 30, 2025. The company also provided a business update that includes signing a $37.8m Supply Assurance Agreement with Merck and organizational changes, together will allow the company to extend its cash runway through 2027. “We’ve had a very exciting and important few months that have set us up very well for the changes we are announcing today” said Stephen Dilly, MBBS, PhD, CEO and Chairman at...

Dallas, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) — NL Industries, Inc. (NYSE: NL) today reported a net loss attributable to NL stockholders of $7.8 million, or $.16 per share, in the third quarter of 2025 compared to net income attributable to NL stockholders of $36.0 million, or $.74 per share, in the third quarter of 2024. NL results include an unrealized loss of $.5 million in the third quarter of 2025 related to the change in value of marketable equity securities compared to an unrealized gain of $18.6 million in the third quarter of 2024. For the first nine months of 2025, NL reported a net loss attributable to NL stockholders of $6.8 million, or $.14 per share, compared to net income attributable to NL stockholders of $50.7 million, or $1.04 per share, for the first nine months of 2024. NL results include an unrealized loss...

Steady Recurring Revenue* Growth and Adjusted EBITDA Margin* Expansion  TORONTO, Nov. 06, 2025 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus Group” or “the Company”) (TSX: AIF), a leading provider of commercial real estate (“CRE”) intelligence, announced today its financial and operating results for the third quarter ended September 30, 2025. Selected Q3 2025 InformationC$M Q3 2025 Q3 2024 % Change % Change CurrencyRevenue $133.3 $128.4 2.2%            Constant Currency*Recurring Revenue* $102.4 $95.4 5.2%          Constant CurrencyProfit (Loss) from continuing operations $0.5 $(2.9) 117.8% As ReportedAdjusted EBITDA* $25.6 $21.6 16.1%     Constant CurrencyAdjusted EBITDA margin* 19.2% 16.8% 230 bps    Constant CurrencyAnalytics Adjusted EBITDA margin* 32.8% 30.3% 250 bps    Constant CurrencyNet cash provided...

SOUTH BEND, Ind., Nov. 06, 2025 (GLOBE NEWSWIRE) — Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) (the “Company”) reported today its operating results for the quarter ended September 30, 2025. FINANCIAL HIGHLIGHTS100% of contractual rents collected. On July 1, 2025, the Company completed the acquisition of nine skilled nursing facilities, comprised of 686 beds, located in Missouri. The acquisition was for $59,000,000 and the Company funded the acquisition utilizing working capital. Eight of the facilities were leased to the Tide Group and were added to their existing master lease that the Company entered into in August 2024. This acquisition increased Tide Group’s annual rents by $5.5 million and subject to 3% annual rent increases. The ninth facility was leased to an affiliate of Reliant Care Group L.L.C. The facility was...

eXp World Holdings Reports Q3 2025 ResultseXp World Holdings Reports Q3 2025 ResultsBELLINGHAM, Wash., Nov. 06, 2025 (GLOBE NEWSWIRE) — eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended September 30, 2025. “Our third quarter results underscore the strength of eXp’s model and the power of our agents,” said Leo Pareja, CEO of eXp Realty. “Continued momentum in agent growth, productivity and retention are driving higher revenue, profitability and overall performance. Our agent-first culture, combined with ongoing innovation across the eXp platform, continues to attract and empower top agents and teams around the world. As we scale, our focus remains on delivering even greater value...

LA JOLLA, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or “Company”) reported net income of $51.5 million, or $1.87 per diluted share, for the third quarter of 2025 compared to net income of $30.5 million, or $1.15 per diluted share, for the third quarter of 2024. Adjusted net income(1) was $55.2 million, or $2.01 per diluted share, for the third quarter of 2025 as compared to $32.4 million, or $1.23 per diluted share, for the third quarter of 2024. Third Quarter 2025 HighlightsGross written premiums increased by 43.9% to $597.2 million compared to $415.0 million in the third quarter of 2024 Net income of $51.5 million compared to $30.5 million in the third quarter of 2024 Adjusted net income(1) increased 70.0% to $55.2 million compared to $32.4 million in the third quarter of 2024 Total...

AUDUBON, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) — Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended September 30, 2025.Worldwide net sales were $769.0 million, an increase of 22.9%, or an increase of 22.3% on a constant currency basis Base business, excluding Nevro, net sales were $669.8 million, an increase of 7.0%, or an increase of 6.5% on a constant currency basis GAAP net income for the quarter was $119.0 million GAAP diluted earnings per share (“EPS”) was $0.88 and non-GAAP diluted EPS was $1.18, increasing 134.0% and 42.6%, respectively“We are pleased with the strength of our overall results and continued progress throughout the company,” commented Keith Pfeil, President and Chief Executive Officer. “Q3 revenue rose 23%, driven by...

Net sales of $1.140 billion, increased 6.0% sequentially and declined 2.0% from the year ago quarter. The midpoint of our guidance provided on August 7, 2025 was net sales of $1.130 billion. On a GAAP basis: gross profit of 55.9%; operating income of $88.9 million and 7.8% of net sales; net income attributable to common stockholders of $13.9 million; and EPS of $0.03 per diluted share. Our guidance provided on August 7, 2025 was for GAAP EPS loss per diluted share of $0.04 to $0.01. On a Non-GAAP basis: gross profit of 56.7%; operating income of $277.2 million and 24.3% of net sales; net income of $199.1 million; and EPS of $0.35 per diluted share. Our guidance provided on August 7, 2025 was for Non-GAAP EPS per diluted share of $0.30 to $0.36. Returned approximately $245.8 million to common stockholders in the September quarter through...